Tetramethylpyrazine alleviates diabetic nephropathy through the activation of Akt signalling pathway in rats.
In the whole world, the principal cause of end-stage renal disease is diabetic nephropathy (DN), which is one of the most relentless complications of diabetes. However, there is a shortfall of compelling DN treatments and the mechanism potentially able to..... Read More